Navigation Links
Global Non-Small Cell Lung Cancer Partnering 2010 to 2017
Date:2/22/2017

NEW YORK, Feb. 22, 2017 /PRNewswire/ -- Summary

Provides understanding and access to the non-small cell lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Read the full report: http://www.reportlinker.com/p03605668-summary/view-report.html

Description
The Global Non-Small Cell Lung Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Read the full report: http://www.reportlinker.com/p03605668-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-non-small-cell-lung-cancer-partnering-2010-to-2017-300412187.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Arthroscopy Devices Market Expected to Reach $5,334 Million, Globally, by 2022
2. Global Psoriasis Drugs Market Outlook 2022 - Research and Markets
3. Radiology Information System Market Expected to Reach $941 Million by 2022, Globally - Allied Market Research
4. Global $2.1 Billion Clot Management Devices Market Analysis & Trends Report 2017: 2013-2015 & 2016-2025 - Research and Markets
5. Global Body Temperature Monitoring Devices Market 2016-2021: Focus on Developing Non Contact Thermometers - Research and Markets
6. Indivumeds Cancer Database Reaches a Global Scale Through Partnership With the National Cancer Tissue Biobank (NCTB), Indian Institute of Technology Madras, Chennai, India
7. Global Patient Monitoring Equipment Market 2017-2021
8. Mass Spectrometer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
9. Micro Guide Catheters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
10. Infusion Pump Market by Product, Application & End User - Global Forecast to 2021
11. Diabetic Shoes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
Breaking Medicine Technology:
(Date:8/16/2017)... California (PRWEB) , ... August 16, 2017 , ... An August 3rd article ... was the subject of a report in JAMA (the Journal of the American Medical Association). ... 50 were able to achieve BMIs under 30, when compared to patients with lower BMIs. ...
(Date:8/16/2017)... ... 16, 2017 , ... For the second year, the Brain ... educate the public on the impact of concussions. Brooke Mills, student and founder ... Awareness Day. , Brooke is working diligently is to raise awareness of concussion ...
(Date:8/16/2017)... Island, NY (PRWEB) , ... August 16, 2017 , ... ... with IV starts and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical ... takes much of the guesswork out of a needle stick and more importantly, helps ...
(Date:8/16/2017)... YORK, NY (PRWEB) , ... August 16, 2017 , ... ... for better treatments and ultimately, a cure. , The grants are awarded through ... comprised of scientists with a wide array of backgrounds and expertise in all areas ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery and ... God's love, and all the many ways God shows love to those who ...
Breaking Medicine News(10 mins):